196 related articles for article (PubMed ID: 1653004)
1. Ifosfamide vs cyclophosphamide in cancer therapy.
Weiss RB
Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group.
Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Verweij J; Dombernowsky P; Onsrud M; Thomas D; Sylvester R
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S180-4. PubMed ID: 8453694
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide in small cell lung cancer.
Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
[TBL] [Abstract][Full Text] [Related]
4. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
[TBL] [Abstract][Full Text] [Related]
5. [Clinical experience with the cytostatic drug ifosfamide].
Ritter S; Schröder HJ
Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
[No Abstract] [Full Text] [Related]
6. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
[TBL] [Abstract][Full Text] [Related]
7. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
Dirix LY; Van Oosterom AT
Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
Saiers JH; Slavik M
Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
[No Abstract] [Full Text] [Related]
9. Ifosfamide in non-small cell lung cancer.
Johnson DH
Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
[TBL] [Abstract][Full Text] [Related]
10. [Ifosfamide in the treatment of small cell carcinoma of the lung].
Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide and mesna.
Schoenike SE; Dana WJ
Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
[TBL] [Abstract][Full Text] [Related]
12. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide in the treatment of breast cancer.
Overmoyer BA
Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
[TBL] [Abstract][Full Text] [Related]
14. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide in the treatment of non-small cell lung cancer.
Ettinger DS
Semin Oncol; 1989 Feb; 16(1 Suppl 3):31-8. PubMed ID: 2539646
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
Schnitker J; Brock N; Burkert H; Fichtner E
Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Vokes EE; Hoffman PC; Masters GA; Golomb HM; Drinkard LC; Krauss SA
Semin Oncol; 1996 Jun; 23(3 Suppl 7):15-8. PubMed ID: 8711496
[TBL] [Abstract][Full Text] [Related]
18. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide.
Zalupski M; Baker LH
J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
